ar-c239 has been researched along with ici 118551 in 1 studies
| Studies (ar-c239) | Trials (ar-c239) | Recent Studies (post-2010) (ar-c239) | Studies (ici 118551) | Trials (ici 118551) | Recent Studies (post-2010) (ici 118551) |
|---|---|---|---|---|---|
| 45 | 0 | 5 | 836 | 31 | 106 |
| Protein | Taxonomy | ar-c239 (IC50) | ici 118551 (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 0.0007 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goepel, M; Michel, MC; Rübben, H; Wittmann, A | 1 |
1 other study(ies) available for ar-c239 and ici 118551
| Article | Year |
|---|---|
Comparison of adrenoceptor subtype expression in porcine and human bladder and prostate.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Binding, Competitive; Female; Humans; Imidazoles; Isoquinolines; Male; Oxymetazoline; Piperazines; Prazosin; Propanolamines; Prostate; Radioligand Assay; Receptors, Adrenergic; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta; Swine; Urinary Bladder; Yohimbine | 1997 |